Science · Pharmacology
what strategies reduce off-target toxicity in kinase inhibitor therapy?
Kinase inhibitors commonly cause off-target toxicity because the ATP-binding pocket is highly conserved across the kinome and many kinases have broad tissue expression. The consequences include dose-limiting adverse events, organ-specific
what role do micrornas play in anticancer drug resistance?
MicroRNAs are short non-coding RNAs that tune protein output by binding messenger RNAs and altering their stability or translation. Victor Ambros at University of Massachusetts Medical School first characterized microRNAs,
do prodrugs improve oral absorption of poorly soluble drugs?
Prodrug strategies can meaningfully increase oral absorption of poorly soluble drugs by altering physicochemical properties or engaging intestinal transport pathways. Prodrugs are chemically modified precursors that release the active drug
what mechanisms underlie drug-induced qt interval prolongation?
Drug-induced prolongation of the QT interval arises from disruptions to the coordinated ionic currents that repolarize ventricular myocytes. Daniel M. Roden Vanderbilt University Medical Center explains that the prototypical direct
how do allosteric modulators change receptor signaling and drug efficacy?
Molecular mechanism and conformational control
Allosteric modulators bind to receptor sites topographically distinct from the orthosteric ligand pocket and alter the receptor’s conformational ensemble. Structural studies by Brian K. Kobilka at
how does plasma protein binding influence drug distribution and clearance?
Mechanisms: binding, distribution, and clearance
Plasma protein binding determines how much of a drug in blood exists in the unbound or free fraction, and that free fraction is what crosses membranes,
how do cytochrome p450 interactions affect drug metabolism?
Cytochrome P450 enzymes sit at the biochemical crossroads of drug clearance. These hepatic and extrahepatic monooxygenases perform oxidative reactions that transform lipophilic drugs into more water-soluble metabolites, altering activity and
which transporters mediate renal drug secretion?
Renal tubular secretion is an active process that moves drugs from the blood into urine, primarily in the proximal tubule. This transport depends on coordinated uptake across the basolateral membrane
how do monoclonal antibodies differ from small-molecule drugs?
Monoclonal antibodies and small-molecule drugs differ fundamentally in origin, size, mechanism, administration, and regulatory treatment, and those differences shape clinical use, safety profiles, manufacturing complexity, and global access.
Molecular size,
what is the impact of genetic polymorphisms on drug response?
Genetic variation can reshape how people respond to medications by altering drug metabolism, target interactions, and immune recognition. Pharmacogenomics studies how common genetic polymorphisms—stable differences in DNA sequence between individuals—modify